Insider · CIK 0001798929

Zummo Jacqueline

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001798929

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-08	TARAProtara Therapeutics, Inc.S Sale	Chief R&D Officer	SSale	−1,134 sh	$5.40	−$6,123.6	94,827
2026-04-01	TARAProtara Therapeutics, Inc.S Sale	Chief R&D Officer	SSale	−22.6K sh	$5.26	−$119K	95,961
2026-01-26	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−3,724 sh	$6.67	−$24.8K	118,559
2026-01-20	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−6,578 sh	$5.60	−$36.8K	122,283
2026-01-16	TARAProtara Therapeutics, Inc.A Award	Chief R&D Officer	AAward	+30K sh	—	—	128,861
2026-01-16	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+180K sh	—	—	180,000
2025-03-26	TARAProtara Therapeutics, Inc.S Sale	Chief R&D Officer	SSale	−21.2K sh	$4.53	−$96.1K	98,861
2025-01-24	TARAProtara Therapeutics, Inc.A Award	Chief R&D Officer	AAward	+24.5K sh	—	—	126,639
2025-01-24	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+146K sh	—	—	146,000
2025-01-21	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−6,554 sh	$4.76	−$31.2K	95,585
2025-01-03	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−2,157 sh	$6.14	−$13.2K	102,139
2024-01-19	TARAProtara Therapeutics, Inc.A Award	Chief R&D Officer	AAward	+23K sh	—	—	107,345
2024-01-19	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−3,049 sh	$1.91	−$5,823.59	104,296
2024-01-19	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+137K sh	—	—	137,000
2024-01-10	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−5,229 sh	$2.39	−$12.5K	84,345
2024-01-03	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−1,899 sh	$2.17	−$4,120.83	89,574
2023-01-19	TARAProtara Therapeutics, Inc.A Award	Chief R&D Officer	AAward	+19.9K sh	—	—	91,473
2023-01-19	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+119K sh	—	—	119,300
2023-01-10	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−5,225 sh	$3.00	−$15.7K	71,573
2023-01-03	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−2,159 sh	$2.80	−$6,045.2	76,798
2022-01-10	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−4,603 sh	$6.27	−$28.9K	78,957
2022-01-03	TARAProtara Therapeutics, Inc.A Award	Chief R&D Officer	AAward	+14.1K sh	—	—	83,560
2022-01-03	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+84.8K sh	—	—	84,800
2021-01-19	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+75K sh	—	—	75,000
2021-01-11	TARAProtara Therapeutics, Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−4,653 sh	$21.16	−$98.5K	69,460
2020-01-10	TARAProtara Therapeutics, Inc.A Award	Chief R&D Officer	AAward	+45.5K sh	—	—	74,113
2020-01-09	TARAProtara Therapeutics, Inc.A Award	Chief R&D Officer	AAward	+28.6K sh	—	—	28,613
2020-01-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+19.1K sh	—	—	19,075
2020-01-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+9,537 sh	—	—	9,537
2020-01-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+9,537 sh	—	—	9,537

Recent filings

Accepted (ET)
Apr 94
Zummo Jacqueline0001213900-26-042079
SEC(opens sec.gov)
Apr 24
Zummo Jacqueline0001213900-26-039328
SEC(opens sec.gov)
Jan 274
Zummo Jacqueline0001213900-26-008223
SEC(opens sec.gov)
Jan 224
Zummo Jacqueline0001213900-26-006708
SEC(opens sec.gov)
Jan 214
Zummo Jacqueline0001213900-26-006225
SEC(opens sec.gov)
Mar 284
Zummo Jacqueline0001013762-25-004101
SEC(opens sec.gov)
Jan 284
Zummo Jacqueline0001213900-25-007532
SEC(opens sec.gov)
Jan 234
Zummo Jacqueline0001213900-25-005963
SEC(opens sec.gov)
Jan 74
Zummo Jacqueline0001213900-25-001646
SEC(opens sec.gov)
Jan 234
Zummo Jacqueline0001213900-24-005724
SEC(opens sec.gov)
Jan 124
Zummo Jacqueline0001213900-24-003335
SEC(opens sec.gov)
Jan 54
Zummo Jacqueline0001213900-24-001546
SEC(opens sec.gov)
Jan 204
Zummo Jacqueline0001213900-23-004082
SEC(opens sec.gov)
Jan 114
Zummo Jacqueline0001213900-23-002266
SEC(opens sec.gov)
Jan 44
Zummo Jacqueline0001213900-23-000857
SEC(opens sec.gov)

Companies

Protara Therapeutics, Inc.Chief R&D OfficerTARA

Address

C/O PROTARA THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 3RD FLOOR

NEW YORK, NY, 10010